Although AS patients tend to have fewer conventional tuberculosis-related comorbidities than rheumatoid arthritis (RA) patients, the growing use of TNF inhibitors to treat AS has raised incidences of tuberculosis to a level similar to that in RA patients [8]. Here, TNF is linked to rheumatoid arthritis.